CLSU.L

Clearstar Inc. (DI)
ClearStar,Inc. - PDMR Shareholdings
29th September 2020, 17:20
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 5011A
ClearStar,Inc.
29 September 2020
 

29 September 2020

 

ClearStar, Inc.

("ClearStar" or the "Company")

 

PDMR Shareholdings

 

ClearStar (AIM: CLSU), a provider of Human Capital Integrity℠ technology-based services specialising in background and medical screening, announces that it has been notified of the following sales of ordinary shares of $0.0001 in the Company ("Ordinary Shares") by persons discharging managerial responsibilities ("PDMR"):

 

 

PDMR

Number of Ordinary Shares sold

Date of the transaction

Price at which the Ordinary Shares were sold

Traci Ivester, Chief Operating Officer

22,500

28 September 2020

50.8 cents (USD) (c. 39.5 pence)

Todd Shoulberg, President, Medical Information Services

100,000

28 September 2020

40.0 pence

 

Following these transactions, Ms Ivester has an interest in 9,000 Ordinary Shares, representing 0.02% of the issued share capital of the Company, and Mr Shoulberg no longer has an interest in the Ordinary Shares of the Company.

 

Enquiries:

 

ClearStar, Inc.

+1 877 796 2559

Robert Vale, Chief Executive Officer

Jennifer Balleza, Chief Financial Officer

 

 

 

finnCap Ltd.

+44 20 7220 0500

Jonny Franklin-Adams, Marc Milmo, Simon Hicks - Corporate Finance

Andrew Burdis, Tim Harper - ECM

 

 

 

Luther Pendragon Ltd.

+44 20 7618 9100

Harry Chathli, Claire Norbury, Joe Quinlan

 

 

 

About ClearStar

 

ClearStar, Inc. is a leading provider of Human Capital IntegritySM technology-based services specialising in background and medical screening. It provides employment intelligence direct to employers and via channel partners/consumer reporting agencies ("CRAs") to support better recruitment and other decisions affecting employees by increasing the quality, reliability, and visibility of information.

 

A seven-time Inc. 5000 honoree and founding member of the Professional Background Screening Association (formerly, 'NAPBS'), ClearStar has provided innovative technology solutions to businesses in the human capital management industry from its corporate offices in Alpharetta, Georgia since 1995. For more information about ClearStar, please visit: www.clearstar.net.

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.               

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Traci Ivester

2.               

Reason for the Notification

a)

Position/status

Chief Operating Officer and PDMR

b)

Initial notification /Amendment

Initial notification

3.   

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ClearStar, Inc.

b)

LEI

213800C2DK3HCM3R9T19

4.   

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of US$0.0001 ("Ordinary Shares")

Identification code

KYG2294M1134

b)

Nature of the transaction

Sale of Ordinary Shares

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

50.8 cents (USD)

22,500

d)

Aggregated information:

·    Aggregated volume

·    Price

See (c) above

e)

Date of the transaction

28 September 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

1.   

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Todd Shoulberg

2.               

Reason for the Notification

a)

Position/status

President, Medical Information Services and PDMR

b)

Initial notification /Amendment

Initial notification

3.   

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ClearStar, Inc.

b)

LEI

213800C2DK3HCM3R9T19

4.   

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of US$0.0001 ("Ordinary Shares")

Identification code

KYG2294M1134

b)

Nature of the transaction

Sale of Ordinary Shares

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

40.0 pence

100,000

d)

Aggregated information:

·    Aggregated volume

·    Price

See (c) above

e)

Date of the transaction

28 September 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKCBDOBKDFCB ]]>
TwitterFacebookLinkedIn